Yahoo! Finance Search - Finance Home - Yahoo! - Help

Wednesday, October 1 2014 2:40pm ET - U.S. Markets close in 1 hour and 20 minutes.
Industry Center - Drug Related Products
Industry Center > Drug Related Products > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Related Products News
Latest News
Wednesday, Oct 1, 2014
·Perrigo Company plc Announces Extension of Exchange Offer for Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043
PR Newswire - Wed 8:53 am ET
·CTD Holdings Names New Board Chairman
Marketwire - Wed 7:00 am ET
Tuesday, Sep 30, 2014
·Natural Alternatives (NAII) Upgraded From Hold to Buy
at - Tue 9:06 am ET
·Inergetics Introduces Surgex® Warrior Sports Nutrition at Winn-Dixie
PR Newswire - Tue 9:00 am ET
Monday, Sep 29, 2014
·Amag, Perrigo Buy Lumara in Two-Step Deal Valued at $1.1B
at - Mon Sep 29
·Auxilium Pharma (AUXL) Upgraded From Sell to Hold
at - Mon Sep 29
·Lumara Health to sell assets to AMAG, Perrigo for $757 million
at MarketWatch - Mon Sep 29
·[$$] Lumara Health to Sell Assets
at The Wall Street Journal Online - Mon Sep 29
·Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals
PR Newswire - Mon Sep 29
·Lumara Health™ to be Acquired in Two Separate Transactions for up to $1.107 Billion
PR Newswire - Mon Sep 29
·Perrigo Enters New Therapeutic Category With The Acquisition Of Women's Health Product Portfolio From Lumara Health
PR Newswire - Mon Sep 29
Thursday, Sep 25, 2014
·Natural Alternatives International, Inc. Announces Fiscal 2014 Results
PR Newswire - Thu Sep 25
Wednesday, Sep 24, 2014
·Inergetics Discovers Unique Combination of Cannabinoids for New Product Line as it Exits Phase II of R&D and Prepares for Final Development Phase
PR Newswire - Wed Sep 24
·#Giants Running Back, Rashad Jennings, Signs Endorsement Deal With USANA Health Sciences
PR Newswire - Wed Sep 24
Tuesday, Sep 23, 2014
·EnzymeBioSystems Announces Progress with an Enzyme Compound
PR Newswire - Tue Sep 23
Monday, Sep 22, 2014
·Auxilium says Endo offer undervalues company, but open to talks
Reuters - Mon Sep 22
·[$$] Auxilium Sticks With QLT's Merger Deal
at The Wall Street Journal Online - Mon Sep 22
·Endo: Buyout offer for Auxilium 'compelling,' provides 'substantial premium'
at MarketWatch - Mon Sep 22
·Endo International Comments On Auxilium Pharmaceutical's Rejection Of Its Acquisition Proposal
PR Newswire - Mon Sep 22
·Auxilium’s Board Rejects Takeover Approach From Endo
at The New York Times - Mon Sep 22
More Latest News...
Sponsor Results
Need a Full Service CRO?
WCCT Global Owns early and late phase CPUs to fit your trial needs.
Professional Statistician
1-on-1 Collaboration for your Project, Research, or Dissertation
Clinical Trial Management
Accelerate clinical trial start-up, site selection, and recruitment.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Related Products Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?